A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Warsaw matriculates Matariki Bioscience
Matarki Bioscience has been spun out under a drug discovery model to carry Warsaw pharmaceutical research through pre-clinical and early clinical trials.
Discern Science embodies UA research
Discern will commercialise a deception tracker nicknamed Avatar designed to initially be deployed at border security and based on research at Arizona.
Bellwether smells the $10m series A coffee
University of California-backed Congruent Ventures is among the investors in Bellwether Coffee, which is marketing an ethical coffee roasting system.
Michigan programs secure $1.6m
Two initiatives open to projects from Michigan institutions have secured continued support from Michigan Strategic Fund.
Nanovis implants $5.5m in funding
Nanovis, a spinal implant nanotechnology developer, has been backed by Elevate Purdue Foundry Fund, which joins existing investors including Apex One Equity Fund.
ProteoMedix discovers $5.3m round
ETH Zurich prostate cancer diagnosis spinout ProteoMedix has now raised $17.4m from investors including Zürcher Kantonalbank.
TeleSense stores $6.5m series A
Food chain monitoring technology developer TeleSense has secured University of California-backed Congruent Ventures as an investor.
DataChemist measures out $1.4m seed round
DataChemist has spun out from Trinity College Dublin with support from University Bridge Fund to commercialise an analytics platform for disorganised data.
Blickfeld catches another glimpse of seed round
Lidar technology developer Blickfeld has secured a $5.7m extension from investors including Unternehmertum Venture Capital Partners to bring its seed round to $10m.
Genomics detects $32.5m series B
Vertex Pharmaceuticals has led a series B round for Genomics, a spinout from University of Oxford that also attracted Oxford Sciences Innovation and IP Group.
645 calls universities for $40m fund
Princeton and Spelman College are among the investors in 645 Ventures’ $40m fund, targeting segments such as online marketplaces and digitally-native consumer brands.
Sutro starts IPO proceedings
A month after Sutro closed an $85.4m series E round, the cancer drug developer, based on research at Stanford, has filed for a $75m initial public offering.
Volumental tunes $1.4m round
KTH foot scanner technology spinout Volumental has secured cash from Forward VC, Walerud Ventures and Moor Capital after previously closing a seed round in 2014.
10x engineers Epinomics acquisition
Epigenomics services provider Epinomics, co-founded by Stanford University faculty and alumni, has been bought by 10x Genomics in a transaction which enables StartX to exit.


